Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients

Abstract

In the civilian setting, plasma, PLT, and cryoprecipitate products significantly increased 30-day survival in trauma patients. Future prospective randomized clinical trials are required to determine the optimal transfusion ratios.